BioSig Technologies [BSGM] vs Boston Scientific [BSX] Detailed Stock Comparison
BioSig Technologies
NASDAQ
Loading...
Boston Scientific
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: BioSig Technologies wins in 7 metrics, Boston Scientific wins in 10 metrics, with 0 ties. Boston Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | BioSig Technologies | Boston Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -7.39 | 57.93 | BioSig Technologies |
| Price-to-Book Ratio | -44.12 | 6.43 | BioSig Technologies |
| Debt-to-Equity Ratio | 0.00 | 53.09 | BioSig Technologies |
| PEG Ratio | -0.05 | 0.40 | BioSig Technologies |
| EV/EBITDA | -7.24 | 33.14 | BioSig Technologies |
| Profit Margin (TTM) | 0.00% | 13.55% | Boston Scientific |
| Operating Margin (TTM) | -211,407.70% | 18.63% | Boston Scientific |
| EBITDA Margin (TTM) | N/A | 18.63% | N/A |
| Return on Equity | 739.31% | 11.55% | BioSig Technologies |
| Return on Assets (TTM) | -30.45% | 5.39% | Boston Scientific |
| Free Cash Flow (TTM) | $-4.76M | $2.37B | Boston Scientific |
| 1-Year Return | 1,746.67% | 15.12% | BioSig Technologies |
| Price-to-Sales Ratio (TTM) | 16,550.19 | 7.80 | Boston Scientific |
| Enterprise Value | $194.33M | $155.93B | Boston Scientific |
| EV/Revenue Ratio | 14,948.37 | 8.43 | Boston Scientific |
| Gross Profit Margin (TTM) | N/A | 67.65% | N/A |
| Revenue per Share (TTM) | $0 | $13 | Boston Scientific |
| Earnings per Share (Diluted) | $-1.05 | $1.68 | Boston Scientific |
| Beta (Stock Volatility) | 1.82 | 0.61 | Boston Scientific |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
BioSig Technologies vs Boston Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| BioSig Technologies | -5.42% | 2.40% | 17.12% | -42.59% | 965.38% | 295.71% |
| Boston Scientific | -0.64% | -0.88% | -9.50% | -6.71% | -1.20% | 8.88% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| BioSig Technologies | 1,746.67% | -31.69% | -89.74% | -86.15% | -93.67% | -93.67% |
| Boston Scientific | 15.12% | 144.77% | 136.56% | 476.54% | 1,487.60% | 312.37% |
News Based Sentiment: BioSig Technologies vs Boston Scientific
BioSig Technologies
News sentiment data is not available for BioSig Technologies at this time.
Boston Scientific
News based Sentiment: POSITIVE
October brought a wave of positive signals for Boston Scientific, including increased institutional investment, raised price targets from multiple firms, and a promising long-range plan. While insider selling remains a point to watch, the overall narrative is one of strong growth potential and investor confidence.
Performance & Financial Health Analysis: BioSig Technologies vs Boston Scientific
| Metric | BSGM | BSX |
|---|---|---|
| Market Information | ||
| Market Cap | $195.40M | $144.20B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 1,060,709 | 12,773,240 |
| 90 Day Avg. Volume | 1,009,203 | 10,174,867 |
| Last Close | $5.24 | $96.70 |
| 52 Week Range | $0.23 - $14.11 | $80.64 - $109.50 |
| % from 52W High | -62.86% | -11.69% |
| All-Time High | $124.30 (May 11, 2020) | $109.50 (Sep 09, 2025) |
| % from All-Time High | -95.78% | -11.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.23% |
| Quarterly Earnings Growth | -1.00% | 1.46% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.14% |
| Operating Margin (TTM) | -2,114.08% | 0.19% |
| Return on Equity (TTM) | 7.39% | 0.12% |
| Debt to Equity (MRQ) | 0.00 | 53.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.12 | $15.14 |
| Cash per Share (MRQ) | $0.09 | $0.36 |
| Operating Cash Flow (TTM) | $-4,356,000 | $4.28B |
| Levered Free Cash Flow (TTM) | $110.50M | $2.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: BioSig Technologies vs Boston Scientific
| Metric | BSGM | BSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -7.39 | 57.93 |
| Forward P/E | -8.03 | 34.88 |
| PEG Ratio | -0.05 | 0.40 |
| Price to Sales (TTM) | 16,550.19 | 7.80 |
| Price to Book (MRQ) | -44.12 | 6.43 |
| Market Capitalization | ||
| Market Capitalization | $195.40M | $144.20B |
| Enterprise Value | $194.33M | $155.93B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14,948.37 | 8.43 |
| Enterprise to EBITDA | -7.24 | 33.14 |
| Risk & Other Metrics | ||
| Beta | 1.82 | 0.61 |
| Book Value per Share (MRQ) | $-0.12 | $15.14 |
Financial Statements Comparison: BioSig Technologies vs Boston Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BSGM | BSX |
|---|---|---|
| Revenue/Sales | $0 | $4.66B |
| Cost of Goods Sold | N/A | $1.45B |
| Gross Profit | N/A | $3.21B |
| Research & Development | $19,000 | $443.00M |
| Operating Income (EBIT) | $-20.37M | $937.00M |
| EBITDA | $-19.81M | $1.23B |
| Pre-Tax Income | $-20.37M | $805.00M |
| Income Tax | $0 | $133.00M |
| Net Income (Profit) | $-20.37M | $672.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BSGM | BSX |
|---|---|---|
| Cash & Equivalents | $3.73M | $725.00M |
| Total Current Assets | $3.99M | $7.34B |
| Total Current Liabilities | $1.68M | $5.06B |
| Long-Term Debt | N/A | $10.93B |
| Total Shareholders Equity | $2.74M | $22.45B |
| Retained Earnings | $-258.16M | $3.35B |
| Property, Plant & Equipment | $814,000 | $448.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BSGM | BSX |
|---|---|---|
| Operating Cash Flow | $-490,000 | $513.00M |
| Capital Expenditures | N/A | $-187.00M |
| Free Cash Flow | $-1.12M | $277.00M |
| Debt Repayment | N/A | $-1.31B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BSGM | BSX |
|---|---|---|
| Shares Short | 1.75M | 19.02M |
| Short Ratio | 2.24 | 2.76 |
| Short % of Float | 0.06% | 0.01% |
| Average Daily Volume (10 Day) | 1,060,709 | 12,773,240 |
| Average Daily Volume (90 Day) | 1,009,203 | 10,174,867 |
| Shares Outstanding | 17.24M | 1.47B |
| Float Shares | 25.53M | 1.48B |
| % Held by Insiders | 0.29% | 0.00% |
| % Held by Institutions | 0.29% | 0.94% |
Dividend Analysis & Yield Comparison: BioSig Technologies vs Boston Scientific
| Metric | BSGM | BSX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |